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This report emphasizes the application of behavior-genetic designs to the study of sensitivity to
toxic chemicals, and features of multiple chemical sensitivity and substance abuse that are polar
opposites. The implications of these issues for future research are discussed in relation to twin,
adoption, and sibling pair studies, as well as in relation to the degree to which genetically selected
lines of rodents that have been developed in the alcoholism field are applicable to multiple
chemical sensitivity. Environ Health Perspect 105(Suppl 2):505-508 (1997)
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Introduction
Miller (1) presents an interesting model of
multiple chemical sensitivity (MCS). It is
similar in many ways to stress-diathesis
models that are ubiquitous in clinical psy-
chology (2). In these theories, a constitu-
tional vulnerability (i.e., diathesis) is
proposed that places an individual at
heightened risk for developing a psychiatric
disease such as alcoholism (3,4). This vul-
nerability may be genetic, environmental,
or a genetic-environmental interaction. If
vulnerable individuals are exposed to sig-
nificant environmental stresses, they may
manifest the disorder. However, ifindivid-
uals at heightened risk are reared in nurtu-
rant, stress-buffering environments, or if
they have other constitutional traits that
protect against the effects of stress, the
disorder may never be expressed clinically.
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In Miller's (1) model, the diathesis for
MCS could be a proneness for loss oftoler-
ance when exposed to toxic chemicals. For
example, an individual may have enhanced
capacity for sensitization processes-both
conditioned and unconditioned-that
would amplify any preexisting aversion to
toxic chemicals or to the odors of those
substances. The stress component of the
stress-diathesis model can be viewed either
as an acute exposure to high levels of a
toxic chemical, such as in an industrial
accident, or as gradual, intermittent expo-
sure to low-level chemicals, such as when a
work building is remodeled.
Behavior Genetics
Table 1 summarizes certain behavior-
genetic designs that are often used to deter-
mine genetic and environmental factors in
psychiatric disorders.
Twins
Sophisticated methods have been devel-
oped to assess the genetic heritability of
psychiatric vulnerabilities (5). If it were
found that MCS tended to run in families
or to demonstrate intergenerational trans-
mission, there would be a possibility that
the disorder had a significant genetic com-
ponent (6). However, this would not pre-
clude the possibility of environmental
transmission because pesticide use patterns,
living or working locations with toxic pollu-
tants, and similar factors could be common
to different generations ofthe same families.
Twin studies may be used to assess the
genetic heritability of MCS. In these
studies, monozygotic and dizygotic twin
pairs are assessed in terms ofclinical mani-
festations ofMCS or a subclinical aversion
to chemicals. Ifthe disorder has a genetic
component, monozygotic twins-who
have identical genes-would be expected
to demonstrate greater concordance for the
disorder or its subclinical manifestation(s)
than dizygotic twins-who share halftheir
genes on average.
The design is simple but the execution
and statistical analyses are not. Twins pairs
must be identified in which one or both of
the twins has MCS or some heightened
aversion to chemicals. The required num-
ber oftwin pairs who meet these criteria to
test the hypothesis of a significant genetic
component is probably in the hundreds
(5,7). This usually necessitates mass mail-
ings of questionnaires to an established
twin registry rather than structured clinical
interviews. It can be expected that using
self-report measures would tend to dilute
the measured effect, so that even more
twin pairs would be needed to provide a
powerful test ofthe genetic hypothesis .
GeneXEnvironment Interacdon
Kendler (7) recently proposed at least two
mechanisms for gene Xenvironment inter-
action: genetic control of exposure to the
environment and genetic control of sensi-
tivity to the environment. In the first
mechanism, an individual may have a
genetic predisposition for exploratory
Table 1. Summary of selected experimental designs in behavior genetics.
Genetic Environmental Interaction (gene
heritability transmission Xenvironment)
Design estimates estimates estimates Additional studies
Family No No No Intergenerational transmission
Twin Yes Yes Yes Discordant MZs; item loadings
Adoptee Yes Yes Yes Item loadings
Sibling pair Yes No No Molecular genetics
Genetically selected Yes Yes Yes Neurophysiology; highlytoxic
lines of rodents incitants
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behavior or sensation-seeking that would
make them more likely to be exposed to
toxic chemicals. In the second mechanism,
an individual may be more sensitive to
environmental toxicity due to genetic pre-
disposition. Kendler (7) discussed mathe-
matical models for studying these potential
mechanisms in psychiatric illness.
Adoptees
A second design that has been used often
to assess genetic effects is the study of
adoptees (8,9). Adoptees who have a bio-
logical parent diagnosed with an MCS dis-
order but who have been placed in foster
homes in which neither foster parent has
an MCS disorder are compared to similar
individuals whose biological parents do not
have an MCS disorder. If the adoptees
whose biological parent(s) have MCS are
more likely to manifest the disorder than
matched adoptees with no family history,
MCS can be said to show a significant
genetic component.
In both twin and adoption designs,
many other hypotheses can be tested.
These include genetic associations with
other disorders (such as alcoholism), the
degree to which MCS in the foster parents
may elevate the adoptees' risk ofmanifest-
ing the disorder due to environmental
transmission, and the study ofdiscordant
monozygotic twins to isolate the environ-
mental etiology or chronic effects ofMCS.
Moreover, these designs allow the researcher
to separate those specific characteristics of
MCS that have significant genetic loadings
from those that do not (10).
Molecular Genetics
If it could be firmly established that there
were a significant genetic component to
MCS, it would then be useful to proceed
to behavioral/molecular family designs
to determine the genetic locus of the
vulnerability. This approach requires that
candidate genes be available that may be
expected to play a role in the disorder
based on theoretical or empirical grounds.
Other candidate genes would be those that
control brain neurotransmitters such as
dopamine, serotonin, orglutamate.
The simplest behavioral/molecular
family design (11) involves studying sibling
pairs-at least one ofwhom has an MCS
disorder-as well as serum collected from
both parents. Assays of DNA from white
blood cells from both siblings and both par-
ents are used to identify polymorphisms
that can be localized on the human genome
and that have known associations with
relevant physiological functions. The
sibling pairs (but not the parents) must be
evaluated clinically for the presence or
absence ofan MCS disorder. The presence
or absence ofrelevant gene polymorphisms
is then related to the presence or absence of
MCS in the siblings. Ifboth siblings have
an MCS disorder, they would both be
expected to possess a relevant polymor-
phism. Ifonly one sibling is diagnosed as
having an MCS disorder, only the affected
individual would be expected to have the
relevant polymorphism. The DNA ofthe
parents is used to further specify the
descent ofthe relevant gene(s) (12,13).
This is a potentially powerful design,
but it is absolutely necessary to replicate
the "hit" with a different sample offamilies
if a gene locus is identified. The design is
prone to false positives, so independent
replication prior to publication is needed
to verify the results (14). In the replication
study, only the gene polymorphism that
had a hit in the first study needs to be
assayed-a major saving in effort and
expense. Sibling pairs are more easily
recruited than twins, and a number of
potential candidate genes have been identi-
fied. However, ifthe true candidate gene
is not among those assayed, the study has
litde or no hope ofdiscovering it.
MCS and Substance Abuse
as Polar Opposites
Miller (1) introduces the term "abdiction"
in MCS patients to denote extreme aver-
sion to chemicals, as opposed to "addic-
tion" to them. There are at least two
possible ways in which addiction (to drugs)
and abdiction (from chemicals) may be
related. First, MCS and substance abuse
may represent polar opposites in the sense
that they have some clinical features that
are diametrically opposed to each other. A
second possibility is that MCS and sub-
stance abuse have the same diathesis that is
expressed alternatively as abdiction or
addiction. The null hypothesis is that they
are entirely orthogonal disorders.
Table 2 lists characteristics that differ
between the two disorders and methodolo-
gies to study them. Several clinical features
that are opposite in MCS and substance
abuse follow.
OrientationtowardChemicals
Substance abusers move toward chemical
stimuli (i.e., drugs) while MCS patients
move away from them (15). This basic
orientation toward affective stimuli is a fun-
damental dimension ofhuman and mam-
malian functioning. Moreover, in animals
this moving toward versus moving away
from stimuli can be measured readily using
autoshaping/sign-tracking procedures. In
these paradigms, the animals literally move
toward or away from conditioned stimuli
that are correlated in time-positively or
negatively-with some biologicallyrelevant
unconditioned stimulus-appetitive or
aversive. This is Pavlovian rather than
operant conditioning (16).
Demographics
The relative demographics appear opposite
in MCS and substance abuse. Substance
abusers are approximately twice as likely to
be men than women (3), and the preva-
lence is moderately inversely correlated
with socioeconomic status. For example,
over the last decade cigarette smoking has
become primarily a poor and working class
phenomenon in the United States (17). In
contrast, the typical MCS patient is a mid-
dle class or professional woman (18). The
age of onset ofsubstance abuse is typically
the teens or early twenties (19), while that
ofMCS is often later. Although the demo-
graphics ofsubstance abuse and addiction
have been well studied in the community,
it is possible that the apparent demograph-
ics of MCS are due to clinical bias.
Middle-aged, educated women may simply
be more likely to seek treatment and to
volunteer for dinical research.
Table 2. Summary ofopposing features ofmultiple chemical sensitivityand substance abuse.
Dimension MCS Substance abuse Methodology
Orientation toward Abdiction; moving Addiction; moving Structured interview; autoshaping/
chemicals away; avoidant toward; sensation- sign tracking; genetic rodent model
seeking
Demographics Educated, middle- Poorly educated Epidemiology; community samples
aged women young men
Sensitization To aversive To rewarding Locomotor activity; brain
properties properties microdialysis
Temperament Shyness Antisociality Self report; behavioral measures
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Sensitization
Current research on substance abuse
proposes that the addictive process can be
represented at least in part by sensitization
to the rewarding effects of abused drugs
(19). In contrast, theorists studying MCS
have proposed that the development ofthe
disorder is due to sensitization to the aver-
sive properties ofchemicals. Therefore, it
may be profitable to study the cortico-
mesolimbic dopamine system and its inter-
action with other neurotransmitter systems
in rodents that are particularly sensitive to
low-level toxic chemicals.
Temperament
Substance abuse is strongly related to
antisocial behavior. For example, individu-
als in the community meeting criteria for
antisocial personality disorder are 27 times
more likely to be substance abusers than
those without this diagnosis (20). In con-
trast, there is evidence (21) that MCS
patients tend toward shyness. These per-
sonality differences reflect temperamental
trait differences that could potentially
reflect underlying genetic diatheses that
differ between substance abuse and MCS.
Naltrexone
These differences between addiction and
abdiction are not exhaustive, nor are they
all well established in empirical studies.
However, the reasoning may be useful in
the development of future research ques-
tions and experimental designs to study
MCS (and substance abuse). For example,
recent evidence (21,22) indicates that the
broad-band opiate antagonist naltrexone
(Revia) is moderately effective in the treat-
ment of alcoholism. One implication of
the argument above is that naltrexone is a
candidate medication for MCS. Although
clinical evidence indicates that MCS
patients often have medication intolerance,
it is possible that an normally inactive
antagonist such as naltrexone may be better
tolerated than active agonists.
Following the argument that MCS and
substance abuse may be polar opposites, an
opiate agonist such as methadone or a
partial agonist/antagonist such as bupre-
norphine may be a candidate medication
for MCS as well. However, many MCS
patients may not tolerate these drugs, so
homeopathic doses may be necessary.
Animal Models
Miller's Postulates
Ifwe assume for the moment that there is a
genetic or environmental association
between MCS and substance abuse, this
association has important implications for
how to develop an animal model of the
disorder. Miller's four postulates (1) pro-
vide an ideal starting point for determining
whether an existing animal model is ade-
quate as a nonhuman analogue for MCS.
For example, the alcohol preferring (P) and
alcohol avoiding (NP) strains of rats and
the high alcohol drinking (HAD) and low
alcohol drinking (LAD) strains developed
through genetic selection by Li and col-
leagues (23) have been shown to meet cri-
teria for an animal model of alcoholism.
Miller's postulates could serve the same
function in MCS research.
Alcohol Preference
Although a number of rodent models of
alcohol and drug abuse have been devel-
oped, the P versus NP and HAD versus
LAD lines ofrats are perhaps the best vali-
dated (23). Therefore, these strains ofani-
mals need to be tested in terms of their
physiological and behavioral responses to
high and low levels of toxic chemicals. To
the extent that MCS and alcoholism repre-
sent polar opposites, we would expect the
NP and LAD rat lines to be highly
avoidant oflow-level toxic chemicals com-
pared to the P and HAD lines, respectively.
Conversely, ifit were found that MCS and
alcoholism represented alternative pheno-
types of the same underlying diathesis in
humans, then we would expect the P and
HAD rats to be more avoidant.
Methods
Wood (24,25) has developed sophisticated
experimental procedures for measuring
behavioral aversion to chemicals in
rodents. In addition, the conditioned place-
preference paradigm (26) has been used
extensively in the behavioral pharmacology
literature to assess both preference for drug
effects and aversion to them.
Liitations
An important limitation of the present
discussion might be that it appears to
assume a psychiatric etiology ofMCS (and
substance abuse). However, both the
behavior genetic designs outlined in the
first part ofthis discussion and the animal
models in the second part are compatible
with etiologic mechanisms that are either
central nervous system (CNS) or non-
CNS. For example, a twin or adoption
study would be equally informative for
psychiatric and immunologic diatheses.
Similarly, animals predisposed to chemical
aversion or attraction would be useful for
studying different mechanisms, whether
CNS or non-CNS, that determined this
orientation. Therefore, a limitation of
these approaches is that they are not
intended to distinguish between different
etiologic models ofMCS but only to reveal
and study genetic and environmental
mechanisms.
Conclusion
The behavior-genetic approach to psycho-
pathology may be particularly useful in
the study of MCS. This discussion has
emphasized ways in which future research
can proceed in this direction using both
human volunteers and animal subjects.
The suggestions are not exhaustive, but
may provide useful starting points. It has
been the experience of many psychologists
and psychiatrists that new diseases/disor-
ders/problems/complaints are taken more
seriously by professionals and by the pub-
lic after they have been shown to have a
significant genetic component. This does
not imply that environmental diseases are
any less valid or distressing than those
with genetic diatheses. It more likely
reflects a political or societal bias in the
medical and lay communities.
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